April 11, 2014 — A University of Colorado Cancer Center study presented at the 2014 annual meeting of the American Association for Cancer Research (AACR) describes a novel method to "manipulate the lipid metabolism in the cancer cell to trick them to use more radiolabeled glucose, the basis of PET [positron emission tomography] scanning," according to Isabel Schlaepfer, Ph.D., investigator at the CU Cancer Center Department of Pharmacology and recipient of a 2014 Minority Scholar Award in Cancer Research from AACR.

April 11, 2014 — Calgary Scientific Inc. announced their latest Class II clearance from the U.S. Food and Drug Administration (FDA). Its enterprise image-viewing solution, ResolutionMD, is now cleared for diagnosis on mobile devices for all imaging modalities. This builds upon their previous clearances for diagnosis using web, iOS and Android devices.


April 11, 2014 — Medtronic announced CE mark and European launch of the Evera MRI SureScan implantable cardioverter-defibrillator (ICD) system, the first and only ICD system approved for magnetic resonance imaging (MRI) scans positioned on any region of the body. The Medtronic Evera MRI ICD is not approved in the United States.
Elekta Philips MRI-guided Radiation Therapy System University Medical Center

Elekta, Royal Philips and University Medical Center (UMC) Utrecht (the Netherlands) announced that the initial components of the world's first high-field magnetic resonance imaging (MRI) guided radiation therapy system are being installed at UMC Utrecht. 

The Ontario Association of Radiologists (OAR) strongly supports the Choosing Wisely Canada (CWC) campaign, launched by the Canadian Medical Assn.


April 10, 2014 — In a presentation exploring the promise of magnetic nanoparticle (mNP) hyperthermia in breast cancer treatment, Dartmouth researcher P. Jack Hoopes, DMV, Ph.D., co-director of Norris Cotton Cancer Center's Nanotechnology Working Group, reviewed preclinical studies conducted at Norris Cotton Cancer Center and discussed plans for early-phase clinical studies in humans at the annual meeting of the American Association for Cancer Research (AACR).

April 10, 2014 — Stephen Wiley of Terrell, Texas, is the first known patient to be treated for vocal cord cancer with the CyberKnife robotic radiosurgery system from Accuray, announced officials from the University of Texas Southwestern Medical Center.

April 10, 2014 — Fuel 3D Technologies Ltd. announced it has secured a £685,831 ($1.1 million) SBRI Healthcare development contract for the development of a 3-D medical imaging system.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now